We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
Wall Street analysts forecast that Agilent Technologies (A - Free Report) will report quarterly earnings of $1.48 per share in its upcoming release, pointing to a year-over-year increase of 8%. It is anticipated that revenues will amount to $1.84 billion, exhibiting an increase of 5.9% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Agilent metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Net Revenue- Applied Markets' should come in at $336.29 million. The estimate indicates a year-over-year change of +3.8%.
Based on the collective assessment of analysts, 'Net Revenue- Agilent Crosslab Group' should arrive at $791.36 million. The estimate indicates a change of +6.4% from the prior-year quarter.
The consensus among analysts is that 'Net Revenue- Life Sciences and Diagnostics Markets Segment' will reach $712.11 million. The estimate indicates a change of +6.3% from the prior-year quarter.
Over the past month, shares of Agilent have returned +11.9% versus the Zacks S&P 500 composite's +2.8% change. Currently, A carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Exploring Analyst Estimates for Agilent (A) Q3 Earnings, Beyond Revenue and EPS
Wall Street analysts forecast that Agilent Technologies (A - Free Report) will report quarterly earnings of $1.48 per share in its upcoming release, pointing to a year-over-year increase of 8%. It is anticipated that revenues will amount to $1.84 billion, exhibiting an increase of 5.9% compared to the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain Agilent metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Net Revenue- Applied Markets' should come in at $336.29 million. The estimate indicates a year-over-year change of +3.8%.
Based on the collective assessment of analysts, 'Net Revenue- Agilent Crosslab Group' should arrive at $791.36 million. The estimate indicates a change of +6.4% from the prior-year quarter.
The consensus among analysts is that 'Net Revenue- Life Sciences and Diagnostics Markets Segment' will reach $712.11 million. The estimate indicates a change of +6.3% from the prior-year quarter.
View all Key Company Metrics for Agilent here>>>Over the past month, shares of Agilent have returned +11.9% versus the Zacks S&P 500 composite's +2.8% change. Currently, A carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .